Timedora

2 Screening and Early Detection

Learn what screening can and cannot establish, how to interpret test results, and how benefits, harms, age, and individual risk shape screening decisions.

Purpose and conditions for

is intended for people who appear well, to identify those who may have a disease or elevated risk before recognizable symptoms develop. It is not the process for evaluating symptoms; symptoms require diagnostic assessment. A positive result is not a diagnosis, but a signal for appropriate follow-up testing.

can improve health only if detection leads to effective care and follow-up is accessible. A sound program considers the condition's importance and natural history, whether earlier detection improves outcomes, test accuracy and acceptability, treatment effectiveness, and the balance of benefits and harms. It also considers the interval and whether the health system can complete diagnostic evaluation and treatment.

Test performance and result categories

A test separates people more likely to have a condition from those less likely to have it. Results can be understood using four categories:

  • True positive: the test is positive and the condition is present.

  • False positive: the test is positive but the condition is absent.

  • False negative: the test is negative but the condition is present.

  • True negative: the test is negative and the condition is absent.

describes how often a test identifies people who have the condition:

Sensitivity=true positivesall people with the condition\text{Sensitivity}=\frac{\text{true positives}}{\text{all people with the condition}}

describes how often a test correctly identifies people who do not have the condition:

Specificity=true negativesall people without the condition\text{Specificity}=\frac{\text{true negatives}}{\text{all people without the condition}}

A highly sensitive test misses fewer cases, while a highly specific test produces fewer false positives. These measures describe test performance, but they do not by themselves tell a person with a positive or negative result how likely the condition is.

Predictive values and

is the chance that a person with a positive result truly has the condition:

PPV=true positivesall positive results\text{PPV}=\frac{\text{true positives}}{\text{all positive results}}

is the chance that a person with a negative result does not have the condition:

NPV=true negativesall negative results\text{NPV}=\frac{\text{true negatives}}{\text{all negative results}}

Unlike and , predictive values depend on : how common the condition is in the screened population. If a condition is uncommon, even a test with good and can produce more false positives relative to true positives. A positive result may therefore need confirmation. Interpret results in light of the person's risk and the test's limitations.

Benefits, harms, and recommendation grades

Potential benefits include finding disease at a stage when treatment is more effective, preventing progression or complications, and reducing illness or death. Earlier detection does not automatically improve outcomes: benefit depends on the entire pathway from through confirmation and treatment.

Potential harms include false-positive results that cause worry and lead to additional tests or procedures, and false-negative results that provide false reassurance or delay diagnosis. means finding a condition that would never have caused symptoms or shortened life; overtreatment is treatment of that condition. and follow-up also take time and effort, and confirmatory tests or treatment can cause physical complications.

A decision weighs outcomes across the relevant population, not merely whether a test can detect disease. The recommendations according to the evidence and the balance of benefits and harms:

  • A and B: recommend offering the service.

  • C: supports selective use based on circumstances and preferences.

  • D: recommends against the service.

  • I: evidence is insufficient to determine the balance of benefits and harms. An I statement is not proof that has no benefit.

Applying recommendations to age and risk

Recommendations generally apply to defined groups, ages, intervals, and risk levels. Age can change both the probability of disease and the potential balance of benefit and harm. Individual risk—such as family history, inherited conditions, prior disease, or exposure history—may call for an approach different from routine for average-risk people. A guideline for asymptomatic, average-risk adults may not apply to someone with symptoms or a high-risk history.

Examples of USPSTF recommendations illustrate how age and risk shape :

  • Breast cancer: For women and other people assigned female at birth at average risk, mammography is recommended every two years from ages 40 through 74. Evidence is insufficient to assess the balance of benefits and harms at age 75 or older. This recommendation does not cover certain people at high risk, such as those with a BRCA mutation or prior high-dose chest radiation.

  • Colorectal cancer: is recommended for average-risk adults ages 45 through 75. From ages 76 through 85, is selective and should account for health, prior , and preferences; is not recommended after age 85. Available strategies include stool-based tests and visualization tests, which have different intervals and follow-up needs.

  • Lung cancer: Annual low-dose CT is recommended for adults ages 50 through 80 with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years. stops after 15 years without smoking or when health limits the person's ability or willingness to undergo curative surgery.

These examples are not a substitute for checking current guidance for a particular person. Recommendations can change, and clinical circumstances and patient preferences matter. For an individual decision, discuss expected benefit, possible harms, alternatives, and what will happen after an abnormal result. Reconsider when age, health, risk, or prior history changes.